JIPOAd
JIPOAd
PARP
ESID
  • Users Online: 163
  • Print this page
  • Email this page

  Editorial Board

Editor-in-Chief:
Aung Naing, MD, FACP
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Twitter: @ANaingMD

Associate Chief Editors:
Jordi Rodon Ahnert, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Timothy A Yap, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Managing Editor:
Valerie Clark, BS
Global Academy for Health Sciences, OH, USA
Twitter: @JIPOEditors

Editorial Board:
Mark Basik, MD
Associate Professor, Department of Surgery and Oncology, Jewish General Hospital, Montreal, QC, Canada

Mehmet Asim Bilen, MD
Emory University, Atlanta, GA, USA
Twitter: @bilenma

Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA

Adi Diab, MD
University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jennifer Gardner, MD
Associate Professor, Division of Dermatology, University of Washington; Director of Medical Education, Melanoma and Skin Oncology, University of Washington Center for One Health Research, Seattle Cancer Care Alliance, Seattle, WA, USA

Ignacio Garrido-Laguna, MD
Associate Professor, Gastrointestinal Oncology; Associate Director of Phase 1 Program, Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
Twitter: @GarridoLagunaMD

Joud Hajjar, MD
Assistant Professor, Service Chief of Adult Allergy and Immunology, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children Hospital, Houston, TX, USA
Twitter: @HajjarJoud

Dov Hershkovitz, MD
Tel-Aviv University, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Abdul Rahman Jazieh, MD, MPH
Professor and Chairman, Dept. of Oncology, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
Twitter: @jaziehoncology

Matthew Krebs, MD
Senior Clinical Lecturer, Division of Cancer Sciences, Dept. of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK

Rebecca Kristeleit, MD
Department of Gynecological Oncology, University College London Hospitals, London, UK

Chia-Chi Lin, MD
Director of Phase 1 Center, Dept. of Oncology, National Taiwan University Hospital, Taiwan

Herbert Loong, MD
Clinical Assistant Professor, Dept. of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Twitter: @herbloong

Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK

Christophe Massard, MD
Senior Consultant, Department of Drug Development, Dept. of Medical Oncology, Gustave Roussy, Villejuif, France
Twitter: @drcmassard

Jennifer McQuade, MD
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Twitter: @mcquadeMDLAc

Rowan Miller, MD
Consultant Medical Oncologist, University College London Hospital, London, UK

Paolo Nuciforo, MD
Principal Investigator, Molecular Oncology Group, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Twitter: @DrMiddlescent

Nir Peled, MD
Head of Oncology Division, The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel

Sophie Postel-Vinay, MD
Assistant Professor, Department of Drug Development, Institut de Cancérologie, Gustave Roussy, Villejuif, France

Christian Rolfo, MD
Professor, Director of Thoracic Medical Oncology, Director of Early Clinical Trials, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
Twitter: @ChristianRolfo

Patricia Roxburgh, MD
Senior Clinical Lecturer, Experimental Therapeutics, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland
Twitter: @RoxburghP

Leonor Trejo, MD
Institute of Pathology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

About the journal
CALL FOR PAPERS
Special issue 2019